Filing Detail
- SEC Home »
- Search the Next-Generation EDGAR System »
- Company Search »
- Current Page
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-21-017696
Filing Date
2021-01-26
Accepted
2021-01-26 16:10:51
Documents
1
Mailing Address
101 MONTGOMERY STREET, SUITE 2550
SAN FRANCISCO CA 94104
Business Address
101 MONTGOMERY STREET, SUITE 2550
SAN FRANCISCO CA 94104
650-391-9740
Eidos Therapeutics, Inc. (Filer)
CIK: 0001731831 (see all company filings)
IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-232999 | Film No.: 21554161
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences